Ms. Kei Tolliver

Esq., Co-Founder and General Counsel

Ms. Tolliver joined Sucampo in May of 1998 as the first full-time employee of the company. She assisted Dr. Ueno and Dr. Kuno to launch the U.S. operations of the company. Since May 2002, Ms. Tolliver has worked as Associate Director of Business Development and was mostly involved in the group’s global operations in Japan and Europe, including General Manager of Sucampo Pharma Europe to set up the Group’s European operations. Ms. Tolliver re-joined Sucampo Pharmaceuticals as Director of Business Development in October 2004. She was closely involved in the company’s major transactions, which include the Initial Public Offering and acquisition of the overseas affiliates in the U.K. and Japan. She became VP of Business Development before leaving Sucampo in 2008 to pursue her long-time goal of obtaining a law degree. She returned to Sucampo as a Board of Director in May 2013.

While working full-time, Ms. Tolliver studied law at Columbus School of Law at Catholic University in Washington D.C., and received her Juris Doctor degree with honors in May 2013. She was a member of the Catholic University Law Review. Mr. Tolliver has been a member of Maryland Bar since December 2013. In 2015, Ms. Tolliver launched her own law practice and is providing legal counsel to start-ups and entrepreneurs leveraging her business experience in working for and growing the start-ups.